K92.1 Melena

Name of the Condition

• Melena (ICD-10 Code: K92.1)

Summary

Melena is the passage of black, tarry stools, indicating the presence of digested blood in the gastrointestinal (GI) tract. This condition typically arises from upper GI bleeding, where blood is exposed to gastric acid and digestive enzymes, resulting in a dark, sticky appearance. It is a clinical sign rather than a standalone disease and requires prompt evaluation to identify the underlying cause.

Causes

Melena is most commonly caused by bleeding from the upper GI tract, including the esophagus, stomach, or duodenum. Potential etiologies include peptic ulcers, gastritis, esophageal varices, Mallory-Weiss tears, or malignancies. Less frequently, it may result from bleeding in the small intestine or rapid transit of blood from the lower GI tract.

Risk Factors

Risk factors for melena often align with those for upper GI bleeding and may include chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs), alcohol abuse, Helicobacter pylori infection, advanced age, or a history of GI disorders. Other contributing factors can include coagulopathy, severe stress, or trauma.

Symptoms

The hallmark symptom is black, foul-smelling stools. Additional signs may include abdominal pain, weakness, dizziness, or signs of hypovolemia (e.g., tachycardia, hypotension). In severe cases, melena may be accompanied by hematemesis (vomiting blood) or syncope.

Diagnosis

Diagnosis involves a thorough patient history, physical examination, and laboratory tests (e.g., complete blood count, stool occult blood test). Endoscopic procedures, such as esophagogastroduodenoscopy (EGD), are often used to locate the source of bleeding. Imaging studies like CT angiography may be employed if endoscopy is inconclusive.

Treatment Options

Treatment focuses on stabilizing the patient, controlling bleeding, and addressing the underlying cause. This may include fluid resuscitation, blood transfusions, proton pump inhibitors, or endoscopic interventions (e.g., clipping, cauterization). Surgical intervention is reserved for cases where bleeding is uncontrolled or recurrent.

Prognosis and Follow-Up

Prognosis depends on the severity of bleeding and the underlying condition. Most cases resolve with appropriate treatment, but recurrent bleeding or complications (e.g., perforation) can occur. Follow-up care typically involves monitoring for recurrence and addressing risk factors (e.g., discontinuing NSAIDs, treating H. pylori).

Complications

Complications of melena include hypovolemic shock, anemia, or perforation of the GI tract. In severe cases, multi-organ failure or death may result if bleeding is not promptly managed.

Lifestyle & Prevention

Preventive measures include avoiding excessive alcohol use, limiting NSAID intake, and managing underlying conditions like H. pylori infection or liver disease. A balanced diet and smoking cessation may also reduce risk.

When to Seek Professional Help

Seek immediate medical attention if you experience black, tarry stools, especially with symptoms like dizziness, weakness, or abdominal pain. Prompt evaluation is critical to prevent life-threatening complications.

Tips for Medical Coders

When coding melena (K92.1), ensure documentation supports the clinical finding and identifies the underlying cause when possible. Note that K92.1 is specific to melena and should not be used for other GI bleeding manifestations. Documentation should clarify whether the condition is acute or chronic and any associated symptoms or interventions.